Cholesterol embolization treated with corticosteroids: Two case reports

Angiology

Volumn 56, Issue 4, 2005, Pages 497-501

  Koga, Jun Ichiro ^a,b   Ohno, Masahiko ^a,b   Okamoto, Kazuhiko ^a,b   Nakasuga, Kazuta ^a,b   Ito, Hiroyuki ^a,b   Nagafuji, Koji ^a,b   Shimono, Nobuyuki ^a,b   Koga, Hideyuki ^a,b   Hayashida, Akihiro ^a,b   Arita, Takeshi ^a,b   Maruyama, Toru ^a,b   Kaji, Yoshikazu ^a,b   Harada, Mine ^a,b  

^a Kyushu University Graduate School of Medical Sciences ^*

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; PREDNISOLONE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CORTICOSTEROID THERAPY; DRUG EFFICACY; FAT EMBOLISM; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; MALE; SKIN BIOPSY;

AGED; ARTERIOSCLEROSIS; CORONARY ANGIOGRAPHY; CREATININE; EMBOLISM, CHOLESTEROL; GLUCOCORTICOIDS; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE;

EID: 22844433701     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600420     Document Type: Article

References (26)

1. Applebaum RM, Kronzon I: Evaluation and management of cholesterol embolization and the blue toe syndrome. Curr Opin Cardiol 11:533-542, 1996.
2. Scolari F, Tardanico R, Zani R, et al: Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36:1089-1109, 2000.
3. Fine MJ, Kapoor W, Falanga V: Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 38:769-784, 1987.
4. Baumann DS, McGraw D, Rubin BG, et al: An institutional experience with arterial atheroembolism. Ann Vasc Surg 8:258-265, 1994.
5. Drost H, Buis B, Haan D, et al: Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J 52:339-342, 1984.
6. Johnson LW, Esente P, Giambartolomei A, et al: Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques. Cathet Cardiovasc Diagn 31:165-172, 1996.
7. Saklayen MG, Gupta S, Suryaprasad A, et al: Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Angiology 48:609-613, 1997.
8. Eggebrecht H, Oldenburg O, Dirsch O, et al: Incidence of atheroembolic renal failure after coronary angiography. A prospective study. Cathet Cardiovasc Interv 49:389-394, 2000.
9. Karalis DG, Quinn V, Victor MF, et al: Risk of catheter-related emboli in patients with atherosclerotic debris in the thoracic aorta. Am Heart J 131: 1149-1155, 1996.
10. Hyman BT, Landas SK, Ashman RF, et al: Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 82:1233-1237, 1987.
11. Dahlberg PJ, Frecentese DF, Cogbill TH: Cholesterol embolism: Experience with 22 histologically proven cases. Surgery 105:737-746, 1989.
12. Vacher-Coponat H, Pache X, Dussol B, et al: Pulmonary-renal syndrome responding to corticosteroids: Consider cholesterol embolization. Nephrol Dial Transplant 12:1977-1979, 1997.
13. Woolfson RG, Lachmann H: Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet 351:1331-1332, 1998.
14. Ferrari E, Taillan B, Drai E, et al: Investigation of the thoracic aorta in cholesterol embolism by transoesophageal echocardiography. Heart 79:133-136, 1998.
15. Fabbian F, Catalano C, Lambertini D, et al: A possible role of corticosteroids in cholesterol crystal embolization. Nephron 83:189-190, 1999.
16. Stabellini N, Rizzioli E, Trapassi MR, et al: Renal cholesterol microembolism: Is steroid therapy effective? Nephron 86:239-240, 2000.
17. Hasegawa M, Kawashima S, Shikano M, et al: The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am J Nephrol 20:263-267, 2000.
18. Nakahama H, Sakaguchi K: Small dose oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant 16:872-873, 2001.
19. Mann SJ, Sos TA: Treatment of atheroembolization with corticosteroids. Am J Hypertens 14:831-834, 2001.
20. Graziani G, Santostasi S, Angelini C, et al: Corticosteroids in cholesterol emboli syndrome. Nephron 87:371-373, 2001.
21. Elinav E, Chajek-Shaul T, Stern M: Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 324:268-269, 2002.
22. Belenfant X, Meyrier A, Jacquot C: Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 33:840-850, 1999.
23. Kaufman JL, Stark K, Brolin RE: Disseminated atheroembolism from extensive degenerative atherosclerosis of the aorta. Surgery 102:63-70, 1987.
24. Colt HG, Begg RJ, Saporito JJ, et al: Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine (Baltimore) 67: 389-400, 1988.
25. Ogan E, Schandene L, Papadopoulos T, et al: Interleukin-5 production by T lymphocytes in atheroembolic disease with hypereosinophilia. J Allergy Clin Immunol 96:427-429, 1995.
26. Cosio FG, Zager RA, Sharma HM: Atheroembolic renal disease causes hypocomplementaemia. Lancet 20:118-121, 1985.